期刊文献+

ADAMTS13和TSP-1在糖尿病视网膜病变的意义 被引量:6

Significance of ADAMTS13 and TSP-1 in diabetic patients
下载PDF
导出
摘要 目的研究血管性血友病因子裂解蛋白酶(ADAMTS13)及凝血酶敏感蛋白-1(TSP-1)与糖尿病眼底视网膜病变(DR)的关系。方法选取114例糖尿病患者分为单纯糖尿病(DM)组38例和糖尿病视网膜病变(DR)组76例,同时选取30例健康体检者作为对照组。用残余胶原结合试验法检测ADAMTS13活性;同时用酶联免疫吸附试验法检测血浆中TSP-1及血管性血友病因子(vWF)抗原水平。结果 DM组患者血浆中ADAMTS13活性低于对照组,差异有统计学意义(P<0.01),vWF抗原和TSP-1水平均高于对照组,差异有统计学意义(P<0.01);DR组ADAMTS13活性明显低于DM组,差异有统计学意义(P<0.05),vWF抗原和TSP-1水平均高于DM组,差异有统计学意义(P<0.05)。结论 ADAMTS13活性降低及TSP-1水平升高可能导致糖尿病眼底视网膜病变的发生和发展。 Objective To study the relationship between von Willebfrand factor cleaving protease ADAMTS13(ADAMTS13)and thrombospondin-1(TSP-1)with diabetic retinopathy(DR).Methods One hundred and fourteen patients with diabetes were divided into the simple diabetes mellitus group(DM group,n=38)and DR group(DR group,n=76),while 30 healthy physcial were selected as control group.The activity level of ADAMTS13 was measured by the residual collagen binding assay,meanwhile the plasma TSP-1and von Willebrand factor(vWF)antigen levels were detected by enzyme linked immunosorbent assay(ELISA).Results The plasma ADAMTS13 activity level in the DM group was lower than that in the control group,the difference was statistically significant(P〈0.01).The levels of vWF antigen and TSP-1were higher than those in the control group,the difference was statistically significant(P〈0.01);the ADAMTS13 activity level in the DR group was significantly lower than that in the DM group,the difference was statistically significant(P〈0.05),while the vWF antigen and TSP-1levels were higher than those in the DM group,the difference was statistically significant(P〈0.05).Conclusion The decrease of ADAMTS13 activity and the increase of TSP-1level may be involved in the occurrence and development of DR.
出处 《检验医学与临床》 CAS 2017年第19期2880-2881,2884,共3页 Laboratory Medicine and Clinic
关键词 糖尿病伴眼底视网膜病变 血管性血友病因子裂解酶 凝血酶敏感蛋白-1 diabetic retinopathy ADAMTS13 thrombospondin-1
  • 相关文献

参考文献3

二级参考文献55

  • 1Peyvandi F, Garagiola I, Baronciani L. Role of yon Willebrand factor in the haemostasis. Blood Transfus,2011 ; 9 ( Suppl 2 ) : s3 - sS.
  • 2Denis CV, Lenting PJ. yon Willebrand factor: at the crossroads of bleeding and thrombosis. Int J Hematol,2012 ;95 (4) :353 -361.
  • 3Campos M,Sun W, Yu F, et al. Genetic determinants of plasma van Willebrand factor antigen levels: a target gene SNP and haplotype a- nalysis of ARIC cohort. Blood,2011 ;117(19) :5224 -5230.
  • 4Hough C, Cameron CL, Notley CR, et al. Influence of a GT repeat ele- ment on shear stress responsiveness of the VWF gene promoter. J Thromb Haemost ,2008 ;6 (7) : 1183 - 1190.
  • 5Hering S, Augustin C, Edelmann J, et al. Complex variability of intron 40 of the van Willebrand factor ( vWF ) gene. Int J Legal Med, 2008 ;122( 1 ) :67 -71.
  • 6de Lange M, de Geus EJ, Kluft C, et al. Genetic influences on fi- brongen, tissue plasminogen activator-antigen and yon Willebrand fac- tor in male and females. Thromb Haemost,2006 ;95 (3) : 414 -419.
  • 7Davies JA, Collins PW, Hathaway LS, et al. Effect of yon Willebrand factor Y/C1584 on in vivo protein level and function and interaction with ABO blood group. Blood, 2007 ; 109 ( 7 ) :2840 - 2846.
  • 8Xie L, Chesterman CN, Hogg PJ. Control of von willebrand factor mul- timer size by thrombospondin-1. J Exp Med,2001 ;193 (12) :1341 - 1349.
  • 9van Schooten C J, Shahbazi S, Groot E, et al. Macrophages contribute to the cellular uptake of yon Willebrand factor and factor VIII in vi- vo. Blood,2008 ;112(5 ) :1704 - 1712.
  • 10Castro-Nunez L, Dienava-Verdoold I, Herczenik E, et al. Shear stress is required for the endocytic uptake of the factor V:- yon Willebrand factor complex by macrophages. J Thromb Haemost, 2012 ; 10 ( 9 ) : 1929 - 1937.

共引文献20

同被引文献49

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部